Invention Grant
- Patent Title: Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors
-
Application No.: US17353313Application Date: 2021-06-21
-
Publication No.: US11359246B2Publication Date: 2022-06-14
- Inventor: Luca Andrea Lotta , Manuel Allen Revez Ferreira , Aris Baras , Parsa Akbari , Olukayode Sosina
- Applicant: Regeneran Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneran Pharmaceuticals, Inc.
- Current Assignee: Regeneran Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Stradley Ronon Stevens & Young, LLP
- Main IPC: C12Q1/6883
- IPC: C12Q1/6883 ; A61P3/04 ; A61K31/7105 ; A61K38/46 ; C12N15/113
Abstract:
The present disclosure provides methods of treating subjects having obesity, methods of identifying subjects having an increased risk of developing obesity, methods of detecting human G-protein coupled receptor 75 variant nucleic acid molecules and variant polypeptides, and GPR75 variant nucleic acid molecules and variant polypeptides.
Information query
